A SARS-CoV-2 RBD vaccine fused to the chemokine MIP-3α elicits sustained murine antibody responses over 12 months and enhanced lung T-cell responses

Overview of attention for article published in Frontiers in immunology, February 2024

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (58th percentile)
Good Attention Score compared to outputs of the same age and source (69th percentile)

Mentioned by

twitter: 5 X users

facebook: 1 Facebook page

Readers on

mendeley: 3 Mendeley

Summary X Facebook

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 70,771 followers.

RT @FrontImmunol: New Research: A SARS-CoV-2 RBD vaccine fused to the chemokine MIP-3α elicits sustained murine antibody responses over 12…

04 Feb 2024

Reply Repost Favourite

MIP-3α (Macrophage Inflammatory Protein-3 alpha) ist wie MTTL3 nur ein anderer Name für CCL20, auch bekannt als LARC (liver and activation-regulated chemokine) 😄 - um das alles nachvollziehen zu können, braucht man eigentlich KI...

03 Feb 2024

Reply Repost Favourite

RT @FrontImmunol: New Research: A SARS-CoV-2 RBD vaccine fused to the chemokine MIP-3α elicits sustained murine antibody responses over 12…

03 Feb 2024

Reply Repost Favourite

SARSCoV2 RBD vac fused to chemokine MIP-3α elicits sustained murine Ab responses over 12mth &⬆️lung Tcell responses. At 12mth postprimary vac, recipients of IM vaccine incorporating MIP-3α had signif,3x⬆️, serum Abs conc than vac not incorporating MIP-

03 Feb 2024

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.